Profile
Wieland W.
Wolf worked as the President & Chief Executive Officer at ProBioGen AG from 2010 to 2020.
Prior to that, he was the Deputy Chairman at Kenta Biotech AG.
From 1993 to 2005, he worked at Rentschler Biopharma SE as a Principal.
Wolf holds a doctorate degree from Universität Salzburg.
Former positions of Wieland W. Wolf
| Companies | Position | End |
|---|---|---|
ProBioGen AG
 ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Chief Executive Officer | 01/06/2020 |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Corporate Officer/Principal | 01/01/2005 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Director/Board Member | - |
Training of Wieland W. Wolf
| Universität Salzburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Health Technology |
ProBioGen AG
ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Commercial Services |
- Stock Market
- Insiders
- Wieland W. Wolf
